Covered recipient · General Payments record
ANTHONY D WEAVER
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2019–2022
$154.87
- Reported across 10 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2022 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $138.79 | 9 |
By paying entity
PY2022 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $35.69 | 2 |
| ITI, Inc. | $18.92 | 1 |
| GlaxoSmithKline, LLC. | $15.48 | 1 |
| Hologic Sales and Service, LLC | $15.01 | 1 |
| Acerta Pharma LLC | $14.24 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $13.95 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $13.24 | 1 |
| Novo Nordisk AS | $12.26 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2022 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $14.24 | 07/06/2022 | Food and Beverage | Undisputed | 01/23/2026 | 915007573 | CMS |
| GlaxoSmithKline, LLC. | $15.48 | 05/18/2022 | Food and Beverage | Undisputed | 01/23/2026 | 944312773 | CMS |
| Hologic, LLC | $15.01 | 08/16/2022 | Food and Beverage | Undisputed | 01/23/2026 | 877673989 | CMS |
| ITI, Inc. | $18.92 | 10/28/2022 | Food and Beverage | Undisputed | 01/23/2026 | 945740743 | CMS |
| Lilly USA, LLC | $14.81 | 10/06/2022 | Food and Beverage | Undisputed | 01/23/2026 | 917880527 | CMS |
| Lilly USA, LLC | $20.88 | 11/10/2022 | Food and Beverage | Undisputed | 01/23/2026 | 917875453 | CMS |
| Novartis Pharmaceuticals Corporation | $13.24 | 10/11/2022 | Food and Beverage | Undisputed | 01/23/2026 | 894444591 | CMS |
| Novo Nordisk Inc | $12.26 | 06/15/2022 | Food and Beverage | Undisputed | 01/23/2026 | 902745515 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $13.95 | 06/07/2022 | Food and Beverage | Undisputed | 01/23/2026 | 955871613 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2022
- Source files
- Dataset page · Bulk file · PY2019 , PY2022
- Generated from
- OP_DTL_GNRL_PGYR2022_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.